denkapparat Operations GmbH Buys Shares of 2,116 Agilent Technologies, Inc. (NYSE:A)

denkapparat Operations GmbH purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,116 shares of the medical research company’s stock, valued at approximately $284,000.

Other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in Agilent Technologies during the fourth quarter worth about $456,963,000. Madison Investment Advisors LLC acquired a new stake in shares of Agilent Technologies during the 4th quarter valued at $94,051,000. FMR LLC boosted its stake in shares of Agilent Technologies by 62.2% during the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock worth $191,193,000 after acquiring an additional 493,947 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Agilent Technologies in the 4th quarter worth $48,172,000. Finally, Worldquant Millennium Advisors LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth $49,449,000.

Agilent Technologies Stock Performance

A stock opened at $119.04 on Friday. The firm has a 50 day moving average of $134.91 and a two-hundred day moving average of $136.80. Agilent Technologies, Inc. has a 12 month low of $117.17 and a 12 month high of $155.35. The company has a market capitalization of $33.94 billion, a price-to-earnings ratio of 27.37, a P/E/G ratio of 3.37 and a beta of 1.11. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

Several analysts have issued reports on A shares. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. Bank of America reduced their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Robert W. Baird lowered their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $150.83.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.